Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spine Asia CoROCO:6758 80 FCF Yield % is 7.15 as of Jul. 17, 2026, which is 163% above its 10-year median of 2.72. GuruFocus rates ROCO:6758 with a GF Score™ of 80/100 and a GF Value™ of NT$48.60 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Spine Asia Co ranks better than 89.82% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Spine Asia Co's FCF Yield % or its related term are showing as below:
ROCO:6758'
s FCF Yield % Range Over the Past 10 Years
Min: 0.07 Med: 2.72 Max: 7.43
Current: 7.15
During the past 10 years, the highest FCF Yield % of Spine Asia Co was 7.43%. The lowest was 0.07%. And the median was 2.72%.
ROCO:6758's FCF Yield % is ranked better than 89.82% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.4
vs ROCO:6758: 7.15
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Spine Asia Co FCF Yield % Related Terms
Spine Asia Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Spine Asia Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6758 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Spine Asia Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spine Asia Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spine Asia Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Spine Asia Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spine Asia Co (ROCO:6758) has a FCF Yield % of 7.15 as of Jul. 17, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Spine Asia Co and its competitors. This is 163% above median its historical median of 2.72. Over the past decade, Spine Asia Co's FCF Yield % has ranged from 0.07 to 7.43. According to the industry distribution chart, Spine Asia Co ranks #87 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 10.2%.
Is Spine Asia Co's FCF Yield % too high?
Spine Asia Co's current FCF Yield % of 7.15 is 163% above median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 7.43. Based on the distribution chart, Spine Asia Co ranks #87 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Spine Asia Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spine Asia Co's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spine Asia Co ranks #87 out of 855 companies for FCF Yield %. This places Spine Asia Co in the top 10% of its industry — outperforming the majority of peers. Historically, Spine Asia Co's own FCF Yield % has ranged from 0.07 to 7.43 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Spine Asia Co and its competitors. Spine Asia Co's current FCF Yield % is 7.15, which is 163% above median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spine Asia Co stock overvalued right now?
Based on GuruFocus' analysis, Spine Asia Co (ROCO:6758) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$48.60, compared to a current price of NT$29.25 — trading 39.8% below its estimated fair value. The current FCF Yield % is 7.15, which is 163% above median its 10-year median of 2.72. Spine Asia Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Spine Asia Co (ROCO:6758), the current FCF Yield % is 7.15 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spine Asia Co (ROCO:6758) Overvalued in 2026?
Based on GuruFocus' analysis, Spine Asia Co stock appears to be undervalued.
The current stock price of NT$29.25 is trading 39.8% below its estimated GF Value™ of NT$48.60.
GuruFocus considers Spine Asia Co to be Significantly Undervalued.
Key valuation signals for ROCO:6758:
FCF Yield %: 7.15 (163% above median its 10-year median of 2.72)
GF Value™: NT$48.60 vs. price of NT$29.25 (39.8% below fair value)
No single metric tells the full story. See the ROCO:6758 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spine Asia Co Ltd is a medical device company. It is engaged in the research, development, manufacturing, and marketing of spinal, implants and instruments. The company offers products such as vigor lumbar peek cage, remond polymer cervical cage, and combo cervical disc cage.
80GF Score
Get the complete analysis for ROCO:6758
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6758 has been successfully added to your 
